Total hip replacement
Conditions
Interventions
control group:Fentanyl intravenous controlled analgesia pump
experimental group :Two dose esketamine intravenous controlled analgesia pumps
Sponsors
The First Affiliated Hospital of Guangxi Medical University
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: Patients undergoing unilateral total hip arthroplasty under elective general anesthesia, sex limited, age 18-80 years, ASA class I to III.
Exclusion criteria
Exclusion criteria: Underwent double hip arthroplasty or hip revision; those with severe liver and kidney dysfunction or cardio cerebrovascular disease; those with untreated or inadequately treated hyperthyroidism; those with a previous history of psychiatric disease or unable to cooperate; any known adverse reaction to the drugs used; those on long-term analgesics.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pain score;Use of other analgesic drugs after operation; | — |
Countries
China
Contacts
Public ContactChengxin Lin
The First Affiliated Hospital of Guangxi Medical University
Outcome results
None listed